Scholarly Index
Mary‐Ellen Taplin
Dana-Farber Cancer Institute; 23,645 total citations; 321 total publications; best world rank #106
Dana-Farber Cancer Institute
23,645Total citations
321Total publications
51H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Prostate Cancer Treatment and Research | Lifetime | 413 | US 227 | 98.79 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 637 | US 313 | 98.05 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 647 | US 260 | 96.95 |
| Hormonal and reproductive studies | Lifetime | 620 | US 307 | 97.16 |
| Cancer, Lipids, and Metabolism | Lifetime | 846 | US 388 | 97.08 |
| PARP inhibition in cancer therapy | Lifetime | 982 | US 411 | 90.80 |
| Prostate Cancer Treatment and Research | 2021-2025 | 106 | US 44 | 98.77 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 234 | US 60 | 93.37 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 445 | US 137 | 95.32 |
| PARP inhibition in cancer therapy | 2021-2025 | 372 | US 143 | 89.38 |